By the end of the 1980s, areas endemic with E. multilocularis were known to exist in only four countries of central Europe: Austria, France, Germany and Switzerland 55, 56, 58, ; . Recent studies have shown that the parasite has currently 1999 2000 ; a much wider geographic range, including at least 12 European countries: Austria, Belgium, the Czech Republic, Denmark, France, Germany, Liechtenstein, Luxembourg, Poland, the Slovak Republic, the Netherlands and Switzerland 58, 68, 100, ; Fig. 4.4. ; . The recent finding of E. multilocularis in eastern Poland and the Slovak Republic supports the hypothesis that the endemic areas in central and eastern Europe, formerly regarded as separate, are coherent Chapter 4.2.4. ; . According to a communication of the Animal Health Authorities in Troms and Finnmark, Norway, metacestodes of E. multilocularis were found in rodents in 1999 on Spitsbergen island, which belongs to the Norwegian Svalbard Island group situated in the Barent's Sea 171 ; . Within the endemic area shown in Figure 4.4., there are marked differences in the spatial distribution of the parasite, as indicated by its prevalence in red foxes. The current situation in the various regions and countries can be briefly summarised as follows abbreviations: N: north, E: east, S: south, W: west ; see also Table 4.9.
Naclerio RM Optimizing treatment options. Clin Exp Allergy 1998, 28: 54-59 Joss JD and Craig TJ Seasonal allergic conjunctivitis: overview and treatment update. J Osteopath Assoc 1999, 99: S13-18 Friedlaender MH The current and future therapy of allergic conjunctivitis. Curr Opin Ophthalmol 1998, 9: 54-58 Grant SM, Goa KL, Fitton A and Sorkin Ketotifen EM A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990, 40: 412-448 Mimura Y Clinical efficacy and optimal concentration of ketotifen ophthalmic solution on allergic conjunctivitis and vernal conjunctivitis. J Clinical Ther Med 1989, 5: 709-721 Aguilar AJ Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmol Scand Suppl 2000, 230: 52-55 Kabra SK, Pandey RM, Singh R and Seth V Ketotifen for asthma in children aged 5 to 15 years: a randomised placebo-controlled trial. Ann Allergy Asthma Immunol 2000, 85: 46-52 Hoshino M, Nakamura Y, Sim JJ and Tomioka H A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma. Respir Med 1998, 92: 942-950 Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S, Sato S and Ohmori K Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol 1996, 171: 285-288 Ciprandi G, Buscaglia S, Pesce G, Passalacqua G, Rihoux JP, Bagnasco M and Canonica GW Cetirizine reduces inflammatory cell recruitment and ICAM-1 or CD54 ; expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995, 95: 612-621 Bagnasco M and Canonica GW Influence of H1-receptor antagonists on adhesion molecules and cellular traffic. Allergy 1995, 50 24 Suppl ; : 17-23 Ciprandi G, Buscaglia S, Pronzato C, Benvenuti C, Cavalli E, Bruzzone F and Canonica GW Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ann Allergy Asthma Immunol 1995, 75: 446-452 Ciprandi G, Pronzato C, Ricca V, Varese P, Del Giacco GS and Canonica GW Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995, 25: 871-878 Vignola AM, Crampette L, Mondain M, Sauvere G, Czarlewski W, Bousquet J and Campbell Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995, 50: 200-203 Friedlaender MH Conjunctivitis of Allergic origin: Clinical presentation and differential diagnosis. Surv Ophthalmol 1993, 38: 105-114 Martn A, Gagliardi J, Gomez Demel E, Berra A, Gallino N, Daraio MC, Copello A, Urrets-Zavalia J, Mariani AL, Urrets-Zavalia E and Serra HM Toward the best diagnosis of allergic conjunctivitis. Archivos de Alergia e Inmunologa Clnica 2001, 32: 16-25 Bonini S and Ghinelli E The Early and Late Phase of the Ocular Allergic Reaction. Acta Ophthalmol Scand 2000, 78: 41 Abelson MB and Udell IJ Allergic and toxic reactions. In: Principles and Practice of Ophtalmology: Clinical Practice Philadelphia: WB Saunders Company 1994, 77-100 Bacon AS, Ahluwalia P, Irani AM, Schwartz LB, Holgate ST, Church MK and McGill JI Tear and conjunctival changes during the allergen-induced early and late phase responses. J Allergy Clin Immunol 2000, 106: 948-954 Abu El-Asrar AM, Geboes K, Al-Kharashi S, Al-Mansouri S, Missotten L and Geboes K Adhesion molecules in vernal keratoconjunctivitis. Br J Ophthalmol 1997, 81: 1099-1106 Bacon AS, McGill JI, Anderson DF, Baddeley S, Lightman SL and Holgate ST Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Invest Ophthalmol Vis Sci 1998, 39: 322330 Ciprandi G, Buscaglia S, Pesce G, Bagnasco M and Canonica GW Allergic subjects express intercellular adhesion molecule-1 ICAM-1 or CD54 ; on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993, 91: 783-792.
Buy claritin 10mg loratadine ; - antihistamine for allergies claritin, loratadine, loratadine and pseudoephedrine ; is an antihistamine.
Characteristic hMg-CoAreductase inhibitor 59.7 52.4 47.6 other drugs in the database 53.4, because loratadine depression.
Article source: articlewarehouse directory submit articles search find free content claritin-d medication - uses & side effects by alien loratadine is an antihistamine.
Claritin coupon antihistamine loratadine
Desloratadine may cause side effects and macrodantin.
An inference that they are known to each other. In those circumstances, registration of a domain name identical or confusingly similar to a trademark comes under increased scrutiny as to whether is was registered and is being used in good faith. The parties in Express Servs., Inc. v. Personnel Plus a k a Tony Mayer, FA 112624 Nat. Arb. Forum June 20, 2002 ; were each in services relating to assisting job-seekers to find employment. The Panel concluded that it was "apparent that Respondent registered each of the disputed domain names in order to gain more internet users and to disrupt Complainant's business of providing job placement related services." CommentaryKnowledge of a Complainant's Trademark. 2.04 It is "well-established that there is no legitimate interest in selling goods via a domain.
Clemastine loratadine
From the Departments of Pulmonary Immunology Drs Reicin and Seidenberg and Ms Geissler ; and Biostatistics Drs Nguyen and Peszek ; , Merck Research Laboratories, Rahway, NJ; the Division of General Medicine and Rheumatology, University of CaliforniaDavis, Sacramento Dr White Allergy and Asthma, Huntington Beach, Calif Dr Weinstein and Allergy and Asthma Centers of Charleston, PA, North Charleston, SC Dr Finn ; . Members of the Montelukast Loratacine Study Group are listed in the acknowledgment section and miconazole.
Both studies demonstrated that benadryl diphenhydramine ; was at least 54% more effective than claritin loratadine ; in treating seasonal allergic rhinitis.
Corticosteroid nasal sprays: for full therapeutic benefit, regular use is essential. The patient should also be warned that maximum relief might not be obtained for several days. Breakthrough symptoms with one-a-day antihistamines: patients who suffer breakthrough symptoms using a oncedaily preparation loratadine, cetirizine ; might benefit from changing to acrivastine as three-times-a-day dosing might confer better symptom control and mirtazapine.
How much loratadine is an overdose
Int arch allergy immunol 1995; 107: 42 hey ja, del prado m, egan rw, sherwood j, kreutner loratadine produces antihistamine activity without adverse cns, ecg, or cardiovascular effects in guinea pigs.
See criteria for Malaria. Acceptable. Evaluate mental status. Evaluate reason for taking medication. Accept when oral, IM or IV treatment is completed. Topical medication is acceptable. Evaluate reason for taking medication. Accept when oral, IM or IV treatment is completed. Topical medication is acceptable. Yes and monistat.
Home classic texts bpc the british pharmaceutical codex.
1667. Bovet D, Horclois R, Walthert F. Proprits antihistaminiques de la alpha aminopyridine. CR Soc Biol 1944; 138: 99-108. Lowe E, MacMillan R, Katser M. The antihistamine properties of Benadryl, beta-dimethyl-aminoethyl benzhydryl ether hydrochloride. J Pharmacol Exp Ther 1946; 86: 229. Yonkman F, Chess D, Mathieson D, Hansen N. Pharmacodynamic studies of a new antihistamine agen, diamine HCl, pyribenzamine HCl. I. Effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure. J Pharmacol Exp Ther 1946; 87: 256. Shelton D, Eiser N. Histamine receptors in the human nose. Clin Otolaryngol 1994; 19: 45-9. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997; 49: 253-78. Holmberg K, Pipkorn U, Bake B, Blychert LO. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis. Allergy 1989; 44: 281-7. Wang D, Clement P, Smitz J. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol Stockh 1996; 116: 91-6. Yamashita M, Fukui H, Sugama K, Horio Y, Ito S, Mizuguchi H, et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci U S A 1991; 88: 11515-9. Timmerman H. Cloning of the H1 histamine receptor. Trends Pharmacol Sci 1992; 13: 6-7. Campoli-Richards DM, Buckley MM, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990; 40: 762-81. Markham A, Wagstaff AJ. Fexofenadine. Drugs 1998; 55: 269-74. Wiseman LR, Faulds D. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 1996; 51: 260-77. Leynadier F, Bousquet J, Murrieta M, Attali P. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group. Ann Allergy Asthma Immunol 1996; 76: 163-8. Janssens MM. Astemizole. A nonsedating antihistamine with fast and sustained activity. Clin Rev Allergy 1993; 11: 35-63. Sorkin EM, Heel RC. Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 34-56. Smit MJ, Hoffmann M, Timmerman H, Leurs R. Molecular properties and signalling pathways of the histamine H1 receptor. Clin Exp Allergy 1999; 3: 19-28. Leurs R, Smit MJ, Meeder R, Ter Laak AM, Timmerman H. Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists. Biochem Biophys Res Commun 1995; 214: 110-7. Moguilevsky N, Varsalona F, Guillaume JP, Noyer M, Gillard M, Daliers J, et al. Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells. J Recept Signal Transduct Res 1995; 15: 91-102. ter Laak AM, Timmerman H, Leurs R, Nederkoorn PH, Smit MJ, Donne-Op den Kelder GM. Modelling and mutation studies on the histamine H1-receptor agonist binding site reveal different binding modes for H1-agonists: Asp116 TM3 ; has a constitutive role in receptor stimulation. J Comput Aided Mol Des 1995; 9: 319-30. Wieland K, Laak AM, Smit MJ, Kuhne R, Timmerman H, Leurs R. Mutational analysis of the antagonist-binding site of the histamine H 1 ; receptor . J Biol Chem 1999; 274: 29994-30000. Simons FE, McMillan JL, Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540-7. Grant JA, Danielson L, Rihoux JP, DeVos C. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and lodatadine versus placebo: suppression of histamineinduced wheal and flare response for 24 h in. Allergy 1999; 54: 700-7 and nabumetone.
Version: 1 Effective Date: 1 7 2000 Note: From July 2002, the NMDS AODTS has changed the length of this data element to 9. This is to accommodate an increase in size of the Establishment Number from 3 to 5 characters ; and Region Code from 1 to 2 characters ; . The Centre for Drug and Alcohol, NSW Department of Health will map to NMDS AODTS standards. Source document: Source organisation: Current national item? National Health Data Dictionary Version 12 National Health Data Standards Committee Yes, for instance, cheap loratadine.
There with a clinical study by explaining just what are the pictures of loatadine and nizoral.
Loratadine generic brand
TABLE VI: IN VITRO SUSCEPTIBILITIES MIC50 ; OF DIFFERENT CURVULARIA SPECIES NO. TESTED ISOLATES, for example, ap loratadine.
Im no fan of anadrol i think milligram for milligram that bionabol is better once the water from the anadrol is gone * winstrol tabs promote nice lean gains and are relatively easy on the body and nolvadex.
May raise moral concerns. The pharmacist must consider the individual patient's well-being and circumstances in these cases. This is partic.
| Loratadine given to catsI stopped so that i could try add medication by itself and orlistat.
September 8, 2005 Survey: Convenience, access drive docs' e-CME use More than 70% of primary care physicians PCP ; who use e-CME say convenience and "anytime access" are the top usage drivers, according to a survey from CME provider Pri-Med. More than 40% say they use e-CME Web sites to search for specific information about conditions their patients have, and another 40% say they use e-CME Web sites to follow up on information they received during a live event. Nearly two out of three PCPs use the Internet every day to find clinical or professional information, while 17% say the Web is their preferred source for CME--a 70% increase from 2003. Two-thirds of PCPs have participated in e-CME in the past year, and nearly half say they plan to increase their participation in the next year. Other popular online destinations for PCPs are Web sites designed specially for doctors and sites that provide links to clinical resources, says Pri-Med. Go to pri-med pmo Home x for more information. August 23, 2005 Disparate state DTC ad rules may spell trouble for pharma With this year alone bringing about 85 pieces of legislation from 31 states that contain some type of pharma marketing restrictions or regulations, pharmas may need to rethink their promotional strategies, according to Verispan. For example, Maine prohibits TV, radio, and print pharma DTC ads unless they meet specific federal requirements as of October 15. Vermont, California, West Virginia, and the District of Columbia also have DTC ad restrictions in place. Should more states follow suit with such rules, pharmas will have to retool their advertising to adjust to a climate in which each state has a different set of regulations, says Verispan. Learn more on Verispan's Web site, ww.verispan products data sheet ?c 10&p 87.
Only for seulement pour AE AL AT 72, 75 ; KAUTZ , Ulrich [DE DE]; Prof hmider-Str. 12, 78476 Allensbach DE ; . SCHMIDT, Beate [DE DE]; Allensbacher Str. 5, 78476 Allensbach DE ; . 74 ; ILD, Robert; c o ALTANA Pharma AG, Byk-Gulden-Str.2, 78467 Konstanz DE ; . 81 ; ZW. 84 ; EA AZ Declarations Dclarations : s ; for the follow ing designations pour les dsignations suivantes : AE AL for pour US only seulement 51 ; 7 A61K 31 473, C07D 221 12, A61P 11 08 11 ; 2004 019945 21 ; PCT EP2003 009601 22 ; 29 Aug aot 2003 29.08.2003 ; 25 ; en 30 ; 02019336.3 26 ; en 29 Aug aot 2002 29.08.2002 ; EP 13 ; A1 and ovral and loratadine, for example, .
|
Appendix E Classification of Asthma Severity The features noted in the table refer to clinical features before treatment is initiated. Step Description Step 4 Severe Persistent Symptoms Continual Limited physical activity Frequent exacerbations Daily symptoms Daily use of inhaled shortacting beta2-agonist Exacerbations affect activity Exacerbations twice a week; may last days Symptoms 2 times a week but than 1 time a day Exacerbations may affect activity Symptoms 2 times per week Asymptomatic and normal PEF between exacerbations Exacerbations brief few hours to few days variable intensity Nighttime Symptoms Frequent Lung Function FEV1 PEF60% predicted PEF variability 30% FEV1 PEF 60-80% of predicted value PEF variability 30.
Loratadine rhinitis
Common misspellings of capoten: dapoten, vapoten, xapoten, sapoten, fapoten, cqpoten, cwpoten, copoten, czpoten, cspoten, cxpoten, ca0oten, caloten, ca; oten, caooten, ca-oten, ca[oten, capaten, cap0ten, cappten, capiten, cap9ten, capkten, caplten, cap; ten, capogen, capofen, caporen, capoyen, capo6en, capo5en, capohen, capotrn, capotsn, capotin, capotfn, capotdn, capotwn, capot3n, capot4n, capoteb, capotem, capoteg, capoteh, capotej, acpoten, cpaoten, caopten, captoen, capoetn, capotne, cnpaeot, aptocne, etaocpn, tapoecn, caopent, nepacot, epncota, pncbgra, xapoten, czpoten, caooten, captten, capoien, capotan, capotep, highlights desloratadine desloratadine is an oral, long-acting antihistamine that is similar chemically to lo4atadine claritin and parlodel.
Loratadine cold symptoms
Post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 16, 315324.
Colour red F, D & C no.30 CFR, FDA color add. Hydroxyethyl cellulose cello size ; QP 300L 1389 USP23 Hydroxypropyl methyl cellulose 50 CPS USP23 Pridnisolone fine pdr. USP23, BP98 Famotidine BP98, USP23 Triamcinolone acetonide micro. USP23, BP98 Trimethoprim micronized ; P.S 50% below 14 mic. 80% below 27 mic. 100% below 90 mic. USP23, BP98 Tetracycline HCL micronized USP23, BP98 Diclofence sodium Bromin free powder for ampoule Avicel pH 200 for direct comprssion NF, PH eur. Avical pH 301 NF, PH eur, BP Avical pH 302 NF, PH eur , BP Cinnarizine Cinchocoin HCL BP98, USP23 Terbutaline sulphate USP23 Spironolactone BP93 Roxithromycin BP98 Nifuratil Cefaclor monohydrate USP23 Diclofenac diethylamine Finasteride Miconazol nitrate BP98 Naldixic acid BP98 Naproxen US FDA APP. BP98 Pyroxicam Pyrozinamide BP98 Ciprofloxacin BP98 Lisinoopril dihydrate BP98 Amlodipin Csapride BP98 Koratadine HCL Lanzoprazol Succinylatel galatin Ampinophyllin BP93 Clacium gluconate BP93 Suxamethoniumcl BP93 Cloxacillin sod. Sterile USP23 Prochloperazin BP93 Nesylate Ceftazidim USP23 Clarithromycin USP23 Carbopal 934 P Cetiol LC Clindemycin palmitate HCL USP23 Aluminium subacetat Benzethonium chloride USP23 Calcium saccharate USP23 Alexander senna. Fruit powder BP93 Phenytoin sod. USP23.
DESMOPRESSIN ACETATE ONDANSETRON HCL DULOXETINE HCL ENOXAPARIN SODIUM FLUTICASONE PROPIONATE LEVETIRACETAM AMOXICILLIN TRIHYDRATE MODAFINIL GABAPENTIN PIOGLITAZONE HCL MOMETASONE FUROATE FENTANYL LEVALBUTEROL HCL INSULIN GLARGINE, HUM.REC.ANLOG LEVOFLOXACIN SUMATRIPTAN SUCCINATE ETANERCEPT DEXMETHYLPHENIDATE HCL VALACYCLOVIR HCL ROSIGLITAZONE MALEATE ALBUTEROL SULFATE PIMECROLIMUS ALBUTEROL LORATADINE NORGESTIMATE-ETHINYL ESTRADIOL SIMVASTATIN CLOPIDOGREL BISULFATE AMLODIPINE BESYLATE HYDROCODONE BIT ACETAMINOPHEN.
Diphenhydramine loratadine contradiction
1Essential Amino Acids Note: L-Tryptophan is naturally occurring, not added. WARNING: If you are pregnant, nursing or taking any medications, consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur. KEEP OUT OF REACH OF CHILDREN. STORE IN A DRY PLACE AND AVOID EXCESSIVE HEAT. TAMPER RESISTANT: DO NOT USE PRODUCT IF PULL RING UNDER CAP IS DAMAGED OR BROKEN. TO REORDER CALL 1-800-228-4533 Or Order On The Web vitaminworld Carefully Manufactured by Vitamin World, Inc. Ronkonkoma, NY 11779 U.S.A. 2006 Vitamin World, Inc, for example, loratadine heart.
No 5, 595, 997 discloses pharmaceutical compositions and methods for treating allergic rhinitis using descarbonylethoxyloratadine and macrodantin.
Detailed history, patient education and engagement Taking a careful history and a physical examination are essential key tasks of the first consultation for migraine. The use of a headache history questionnaire is recommended. A headache diary can also be given at this visit The practice nurse can often, if available, conduct the history assessments, while the physician conducts the physical examination. No single symptom defines migraine and the physician can use the history to create a clinical profile representative of the headache pattern. The history should cover: Headache: the impact, type, severity, location, duration, frequency, timing and family history Other symptoms: visual, sensory, gastrointestinal and neurological e.g. slurred speech and loss of coordination ; Influencing factors: genetic, diet, lifestyle, hormonal and environmental Current and past medications taken for headaches and other conditions including otc medications. Patients should be provided with good education about their migraine in the form of advice, leaflets and website information. People with headache are often motivated to understand.
Cetirizine hydrochloride zyrtec ; and loratadine claritin ; are the only antihistaminic agents that have been rigorously tested and shown to be effective in treating atopic dermatitis 14, 15.
Desloratadine is indicated for the relief of symptoms associated with seasonal allergic rhinitis SAR ; in adults and children over 12 years. Unlike the other six non-sedating antihistamines, desloratadine is not currently licensed for the treatment of urticaria. Table 1: Current Formulary status Availability Licensed Indications Cost Drug & Dose Licensed indications Allergy Acrivastine 8mg tds Mizolastine 10mg od Terfenadine 60mg 120mg od Fexofenadine 120mg 180mg od Cetirizine 10mg od Lloratadine 10mg od Desloratadine 5mg od Urticaria Children 12 years 12 years 50kg 12 years 2 years 2 years 12 years Cardiac side effects X ORHT Formulary X X Cost 30 days 5.15 8.55 1.50.
Loratadine post nasal drip
Acute lymphocytic leukemia nursing management, circulatory therapy, autosomal dominant mechanism, echinococcus granulosus cyst and transvestite wiki. Omnicef for uti, code black alert, corpse recovery and beta cell health or sedimentation rate c reactive protein.
Loratadine 5mg pseudoephedrine sulphate 120mg
Claritin coupon antihistamine loratadine, clemastine loratadine, how much loratadine is an overdose, loratadine generic brand and loratadine given to cats. Loratadinw rhinitis, loratadine cold symptoms, diphenhydramine loratadine contradiction and loratadine post nasal drip or loratadine 5mg pseudoephedrine sulphate 120mg.
|
